Hospital Vall d'Hebron-ko ikertzaileekin lankidetzan egindako argitalpenak (39)

2023

  1. A second update on mapping the human genetic architecture of COVID-19

    Nature

2022

  1. Effect of COVID-19 Pandemic on Invasive Pneumococcal Disease in Children, Catalonia, Spain

    Emerging Infectious Diseases, Vol. 28, Núm. 11, pp. 2321-2325

  2. Four-month incidence of suicidal thoughts and behaviors among healthcare workers after the first wave of the Spain COVID-19 pandemic

    Journal of Psychiatric Research, Vol. 149, pp. 10-17

  3. Novel genes and sex differences in COVID-19 severity

    Human molecular genetics, Vol. 31, Núm. 22, pp. 3789-3806

2021

  1. Necrotizing pneumonia due to Streptococcus pneumoniae in children during the period of non-systematic use of PCV13 in Catalonia, Spain

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 39, Núm. 10, pp. 486-492

  2. Serotypes and Clonal Composition of Streptococcus pneumoniae Isolates Causing IPD in Children and Adults in Catalonia before 2013 to 2015 and after 2017 to 2019 Systematic Introduction of PCV13

    Microbiology Spectrum, Vol. 9, Núm. 3

2020

  1. Effect of antiviral treatment in older patients hospitalized with confirmed influenza

    Antiviral Research, Vol. 178

  2. Erratum for Hernández et al., "Invasive Pneumococcal Disease and Influenza Activity in a Pediatric Population: Impact of PCV13 Vaccination in Epidemic and Nonepidemic Influenza Periods"

    Journal of clinical microbiology

  3. Failures of 13-valent conjugated pneumococcal vaccine in age-appropriately vaccinated children 2-59 months of age, Spain

    Emerging Infectious Diseases, Vol. 26, Núm. 6, pp. 1147-1155

  4. Impact of the 13-valent conjugated pneumococcal vaccine on the direct costs of invasive pneumococcal disease requiring hospital admission in children aged < 5 years: A prospective study

    Vaccines, Vol. 8, Núm. 3, pp. 1-17

  5. Serotype and clonal distribution dynamics of invasive pneumococcal strains after PCV13 introduction (2011-2016): Surveillance data from 23 sites in Catalonia, Spain

    PLoS ONE, Vol. 15, Núm. 2

2019

  1. Alkylphenolic compounds and risk of breast and prostate cancer in the MCC-Spain study

    Environment International, Vol. 122, pp. 389-399

  2. Complicated pneumococcal pneumonia with pleural effusion or empyema in the 13-valent pneumococcal conjugate vaccine era

    Pediatric Pulmonology, Vol. 54, Núm. 5, pp. 517-524

  3. Invasive pneumococcal disease and influenza activity in a pediatric population: Impact of PCV13 vaccination in pandemic and nonpandemic influenza periods

    Journal of Clinical Microbiology, Vol. 57, Núm. 8

2018

  1. Repeated influenza vaccination for preventing severe and fatal influenza infection in older adults: A multicentre case-control study

    CMAJ, Vol. 190, Núm. 1, pp. E3-E12

2017

  1. Costs associated with influenza-related hospitalization in the elderly

    Human Vaccines and Immunotherapeutics, Vol. 13, Núm. 2, pp. 412-416

  2. Effectiveness of 23-valent pneumococcal polysaccharide vaccination in preventing community-acquired pneumonia hospitalization and severe outcomes in the elderly in Spain

    PLoS ONE, Vol. 12, Núm. 2

  3. Effectiveness of the 13-valent pneumococcal conjugate vaccine in preventing invasive pneumococcal disease in children aged 7-59 months. A matched case-control study

    PLoS ONE, Vol. 12, Núm. 8

  4. Factors associated with 30-day mortality in elderly inpatients with community acquired pneumonia during 2 influenza seasons

    Human Vaccines and Immunotherapeutics, Vol. 13, Núm. 2, pp. 450-455

  5. The effectiveness of influenza vaccination in preventing hospitalisations of elderly individuals in two influenza seasons: A multicentre case–control study, Spain, 2013/14 and 2014/15

    Eurosurveillance, Vol. 22, Núm. 34